GOLDMAN SACHS GROUP INC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 43 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$2,958,000
+63.2%
2,000,000
+45.5%
0.00%
Q2 2021$1,812,000
+0.9%
1,375,0000.0%0.00%
Q1 2021$1,796,000
-46.7%
1,375,0000.0%0.00%
-100.0%
Q4 2020$3,371,000
+18.2%
1,375,0000.0%0.00%0.0%
Q3 2020$2,851,000
-9.7%
1,375,0000.0%0.00%0.0%
Q2 2020$3,156,0001,375,0000.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
DLD Asset Management, LP 10,370,000$18,432,6751.98%
Worth Venture Partners, LLC 1,431,000$2,536,6771.50%
CSS LLC/IL 8,197,000$14,535,1420.95%
TENOR CAPITAL MANAGEMENT Co., L.P. 5,198,000$9,252,6470.20%
Warberg Asset Management LLC 517,000$911,5800.18%
BOOTHBAY FUND MANAGEMENT, LLC 3,889,000$6,893,8770.16%
PALISADE CAPITAL MANAGEMENT, LP 1,000,000$1,765,6250.05%
Point72 Asset Management, L.P. 9,007,000$15,925,0090.05%
CAPSTONE INVESTMENT ADVISORS, LLC 5,082,000$8,984,9760.04%
D. E. Shaw & Co., Inc. 11,089,000$19,645,1130.02%
View complete list of SAREPTA THERAPEUTICS INC shareholders